PMC12634801 Paschou IA, Sali E, Paschou SA, Psaltopoulou T, Nicolaidou E, Stratigos AJ
By helping to regulate blood sugar and support healthy weight loss, GLP-1 medications can reduce inflammation, improve mobility, and enhance the effectiveness of physical therapy and rehabilitation programs
If you see a GLP-1 patch advertised on social media, treat it with extreme caution
BI reported in October that Omada Health had filed its S-1 this summer
Its important to play the long game rather than pursue rapid weight loss
CagriSema Quick Start CagriSema is the once-weekly fixed-dose combination of cagrilintide 2.4 mg(a long-acting amylin analogue) and semaglutide 2.4 mg (a GLP-1 receptor agonist) developed by Novo Nordisk for chronic weight management